"With Added Features, Newsletter Aims to Decode the Biotechnology Sector into Layman Terms".Health/Medical Editors BIOWIRE2K CHICAGO--(BUSINESS WIRE) July 20, 2000 Due in part to the announcement that the sequencing phase of the human genome The human genome is the genome of Homo sapiens, which is composed of 24 distinct pairs of chromosomes (22 autosomal + X + Y) with a total of approximately 3 billion DNA base pairs containing an estimated 20,000–25,000 genes. is complete, enthusiasm for the biotechnology industry is mounting. Even with its increasing visibility, there is still a paucity pau·ci·ty n. 1. Smallness of number; fewness. 2. Scarcity; dearth: a paucity of natural resources. of biotechnology information aimed at those lacking a medical or scientific degree. In fact, sometimes simply reading a biotechnology company's press release requires a translator. Fortunately, one industry newsletter hopes to change this. Now entering its third year of publication, the Beck On Biotech bi·o·tech n. Informal Biotechnology. biotech Noun short for biotechnology Noun 1. (http://www.beckonbiotech.com) newsletter helps individuals navigate (1) "Surfing the Web." To move from page to page on the Web. (2) To move through the menu structure in a software application. the sea of scientific jargon jargon, pejorative term applied to speech or writing that is considered meaningless, unintelligible, or ugly. In one sense the term is applied to the special language of a profession, which may be unnecessarily complicated, e.g., "medical jargon. and vocabulary by decoding de·code tr.v. de·cod·ed, de·cod·ing, de·codes 1. To convert from code into plain text. 2. To convert from a scrambled electronic signal into an interpretable one. 3. the biotechnology sector into layman's terms. The newsletter, which is distributed monthly to industry executives, investors and members of the media, provides insight into many different aspects of the biotechnology & pharmaceutical sector. Additionally, issues frequently feature a "company spotlight" that details individual companies who offer unique value or technology. More recently, interviews with leading biotechnology industry executives and an educational series describing various aspects of biotechnology have been added to the newsletter Internet site. "Several years ago, I recognized that the biotechnology industry was severely neglected and not adequately covered by analysts," said Beck On Biotech newsletter editor Michael Becker. "Sensing an opportunity to help educate and inform individuals regarding opportunities presented by the sector, I decided to create an industry newsletter and Internet site to communicate what I felt was nothing short of a biotechnology revolution," said Becker. For information regarding the Beck On Biotech newsletter, contact Michael Becker at 312/431-1700 ext. 451, via email at editor@beckonbiotech.com, or visit the web site for sample issues and further information at: http://www.beckonbiotech.com All comments and opinions are solely those of Michael Becker and are not in any way comments or opinions of Wayne Hummer Investments LLC (Logical Link Control) See "LANs" under data link protocol. LLC - Logical Link Control . Additional information is available upon request. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion